Clinical trials
Recruiting Overweight trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
482 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2016 | 2 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 16 |
| 2023 | 27 |
| 2024 | 62 |
| 2025 | 142 |
| 2026 | 214 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 482 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 25 |
| Eli Lilly and Company | 21 |
| Hoffmann-La Roche | 6 |
| Johns Hopkins University | 6 |
| Pfizer | 6 |
| University of Kansas Medical Center | 6 |
| Amgen | 4 |
| AstraZeneca | 4 |
| Gan & Lee Pharmaceuticals. | 4 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 482 |
| Obesity | 448 |
| Diabetes Mellitus, Type 2 | 53 |
| Weight Loss | 44 |
| Insulin Resistance | 29 |
| Metabolic Syndrome | 21 |
| Prediabetic State | 21 |
| Diabetes Mellitus | 20 |
| Hypertension | 19 |
| Cardiovascular Diseases | 12 |
Trials
Showing 1 to 25 of 482. Each trial links to its page on Pharma Observatory.
382 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.